IL2 and inflammatory bowel disease: No differences were observed in IFN-γ and IL-2 quantities at all postvaccination time points, aside from an increased production of IL-2 in mRNA-1273–vaccinated patients with IBD on day 115 and day 205 (Supplemental Figure 2A).